Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
6
×
Tags
diagnostics
6
×
national blog main
texas blog main
texas top stories
6
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
wisconsin blog main
wisconsin top stories
merck
novartis
startups
abbvie
alzheimer's disease
amgen
cancer
deals
gilead sciences
immunotherapy
medicare
pfizer
What
bio
drug
roundup
new
acquisitions
biggest
ceo
patients
way
accelerator
advantages
albert
announced
approval
bar
biogen’s
biopharmaceutical
bourla
brings
build
buy
cancer
centers
chosen
class
cohort
companies
company
company’s
convo
crispr
cut
dallas
daniel
debut
debuts
depression
dyne’s
earlier
event
Language
unset
unknown
Current search:
diagnostics
×
photo
×
" texas top stories "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Health Wildcatters Splits Program in Two, Debuts Latest Startup Class
@xconomy.com
5 years ago
Will New Study Cut Guesswork for Depression Medicine Prescriptions?